Evaluation of a clinical decision-making aid for nutrition advice in age-related macular degeneration

Abstract

Age-related macular disease (AMD) is a multifactorial degenerative condition affecting the central area of the retina. Patients with AMD report that eye care practitioners are not giving consistent advice regarding nutrition and reported confusion as to what advice, if any, to follow. The aim of this study was to design and conduct a preliminary evaluation of a flowchart to support eye care practitioners in providing accurate, evidence-based nutritional advice to their patients. A flowchart was designed to take practitioners through a decision-making process that would determine whether a patient matched the Age-Related Eye Disease Study (AREDS) 2 eligibility criteria for supplementation. The flowchart was evaluated using a qualified and student optometrist cohort, with both cohorts completing confidence scales and students completing clinical scenarios. Qualified participants showed a significant increase in confidence scores from the initial survey (M = 69.7%, standard deviation [SD] = 16.2%) to the second survey after use of the flowchart for 2 weeks (M = 82.1%, SD = 11.6%; t(45) = 7.33, p < .001; rs = .61, p < .001). The student participants also increased confidence scored after receiving the flowchart (M of first survey = 41.7, SD = 14.6; M of second survey = 69.1, SD = 1.7; t(25) = 7.92, d = .81, p < .001) and increased the number of correct answers on five clinical scenarios. Overall, the flowchart has proved to be useful in boosting the self-efficacy of both qualified practitioners and student practitioners, as well as improving clinical decisions made by student practitioners.

Keywords

Get full access to this article

View all access options for this article.

References

Age-Related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119, 1417–1436.

Age-Related Eye Disease Study 2. (2013, May 19). What does it mean in practice? Optician, p. 20.

Bailey

R. A.

Pfiefer

Shillington

A. C.

Harshaw

Funnell

M. M.

VanWingen

Col

(2016). Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict. BMC Health Services Research, 16, Article 10.

Beatty

Nolan

Kavanagh

O’Donovan

(2004). Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Archives of Biochemistry and Biophysics, 430, 70–76.

Chapin

J. R.

Coleman

Varner

(2011). Yes we can! Improving medical screening for intimate partner violence through self-efficacy. Journal of Injury & Violence Research, 3, 19–23.

Chew

E. Y.

Clemon

T. E.

SanGiovanni

J. P.

Danis

Ferris

F. L.

Elman

. . . Speduto

(2013). Lutein plus zeaxanthin and omega-3 fatty acids for age-related macular degeneration the age-related eye disease study 2 (AREDS2) randomized clinical trial. Journal of the American Medical Association, 309, 2005–2015.

Declaration of Helsinki. (2009). Ethical principles for medical research involving human subjects. Journal of the Indian Medical Association, 107, 403–405.

EU Directive. (2002). Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Communities: Legislation, 45, 51–57.

Hosseini

H. R. J.

Mosallaei

Kalameh

K. A.

(2009). The effect of nutrition and supplements on ocular health. Iranian Red Crescent Medical Journal, 11(1), 10–17.

10.

Kent

(2007). AMD and nutrition: The missing message. Review of Ophthalmology, 14(8), 31–37.

11.

Lyons

Dunson-Strane

Sherman

(2014). The joys of caring for older adults: Training practitioners to empower older adults. Journal of Community Health, 39, 464–470.

12.

National Institute for Health and Care Excellence (NICE). (2008). Mental wellbeing and older people. Public health guidline (PH16). London: NICE

13.

Owen

Jarrar

Wormald

Cook

D. G.

Fletcher

A. E.

Rudnicka

A. R.

(2012). The estimated prevalence and incidence of late stage age related macular degeneration in the UK. British Journal of Ophthalmology, 96, 752–756.

14.

Phansalkara

Weir

C. R.

Morrisa

A. H.

Warner

H. R.

(2008). Clinicians’ perceptions about use of computerized protocols: A multicenter study. International Journal of Medical Informatics, 77, 184–193.

15.

Royal National Institute of Blind People. (2013). AMD information. Retrieved from http://www.rnib.org.uk/eyehealth/eyeconditions/conditionsac/pages/amd.aspx

16.

Smick

(2014). U.S. Optometrists begin global initiative of eye disease prevention. Points de Vue. Available at: http://www.pointsdevue.com/article/us-optometrists-begin-global-initiative-eye-disease-prevention

17.

Stevens

Bartlett

H. E.

Cooke

(2015). Dietary analysis and nutritional behaviour in people with and without age-related macular disease. Clinical Nutrition ESPEN, 10, e112–e117.

18.

Stevens

Bartlett

H. E.

Cooke

Walsh

(2014). Age-related macular degeneration patients’ awareness of nutritional factors. British Journal of Visual Impairment, 32, 77–93.

19.

Turner

K. M. T.

Nicholson

J. M.

Sanders

M. R.

(2011). The role of practitioner self-efficacy, training, program and workplace factors on the implementation of an evidence-based parenting intervention in primary care. Journal of Primary Prevention, 32, 95–112.

20.

Vision 2020 UK. (2012). The Macular Disease Society press release: NHS seriously underestimating cost of elderly eye disease. Retrieved from http://www.vision2020uk.org.uk/macular-disease-society-press-release-nhs-seriously-underestimating-cost-of-elderly-eye-disease

21.

Watkins

Harvey

Langley

Grey

Faulkner

(1999). General practitioners’ use of guidelines in the consultation and their attitudes to them. British Journal of General Practice, 49, 11–15.